Quel est le prix pour Poolbeg Pharma PLC (POLB)

Le prix pour Poolbeg Pharma PLC (POLB) est $0.11565963

Quelle est la capitalisation boursière pour Poolbeg Pharma PLC (POLB)

La capitalisation boursière pour Poolbeg Pharma PLC (POLB) est $882.99K

Poolbeg Pharma PLC (POLB) Prix et Capitalisation Boursière

Poolbeg Pharma plc is a clinical-stage biopharmaceutical company based in the United Kingdom, focused on developing treatments for infectious diseases. Its pipeline features several key programs: POLB 001, a p38 MAP Kinase inhibitor intended for severe influenza; POLB 002, a pioneering, in-licensed RNA-based immunotherapy administered intranasally to combat respiratory virus infections; and POLB 003, an intramuscular vaccine aimed at preventing Melioidosis. Beyond specific therapeutic candidates, Poolbeg also holds licensed access to advanced micro- and nanoencapsulation technology for an oral vaccine delivery system designed to stimulate gut immunity. The company further advances its research through an artificial intelligence-powered drug program. Additionally, Poolbeg is developing a biomarker platform to identify individuals at high risk of severe disease, alongside a model-derived vaccine discovery platform to pinpoint novel vaccine candidates. Incorporated in 2021, Poolbeg Pharma plc is headquartered in London.

Prix pour POLB	L’actif B	La capitalisation boursière de B	Résultats
$714,304 $882.99K	NVDA	$5.453T	+617,591,455.16%
$587,612 $882.99K	AAPL	$4.486T	+508,052,746.39%
$544,802 $882.99K	GOOG	$4.159T	+471,038,578.33%
$483,503 $882.99K	MSFT	$3.691T	+418,039,509.66%
$372,396 $882.99K	AMZN	$2.843T	+321,975,371.68%

Prix pour POLB

L’actif B

La capitalisation boursière de B

Résultats

$714,304 $882.99K